This Small Business Innovation Research (SBIR) grant is designed to stimulate the development of cutting-edge therapeutic and monitoring technologies for Type 1 Diabetes (T1D). It specifically seeks proposals from small business concerns (SBCs) focused on creating an integrated, long-term glucose-regulated insulin delivery system, often referred to as an artificial pancreas. The grant aims to foster innovation that significantly advances T1D management. Utilizing the SBIR (R43/R44) mechanisms, this opportunity supports Phase I, Phase II, and Fast-Track applications. An estimated $3.2 million is available for fiscal year 2011 to fund 5-10 promising projects, empowering small businesses to contribute vital solutions to this critical health challenge.
Opportunity ID: 54672
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-10-008 |
| Funding Opportunity Title: | Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)] |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 19, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 29, 2010 |
| Current Closing Date for Applications: | Nov 29, 2010 |
| Archive Date: | Dec 30, 2010 |
| Estimated Total Program Funding: | $3,200,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. This FOA solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward an integrated long term glucose regulated insulin delivery system (artificial pancreas). Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 5-10 projects awarded as a result of this announcement is $ 3.2M for fiscal year 2011. Future year amounts will depend on annual appropriations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-10-008.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00018766 | Oct 29, 2010 | Nov 29, 2010 | View |
Package 1
Mandatory forms
54672 RR_SF424_1_2-1.2.pdf
54672 SBIR_STTR_Information_1_1-1.1.pdf
54672 PerformanceSite_1_3-1.3.pdf
54672 RR_OtherProjectInfo_1_2-1.2.pdf
54672 RR_KeyPersonExpanded_1_2-1.2.pdf
54672 RR_Budget-1.1.pdf
54672 PHS398_CoverPageSupplement_1_4-1.4.pdf
54672 PHS398_ResearchPlan_1_3-1.3.pdf
54672 PHS398_Checklist_1_3-1.3.pdf
Optional forms
54672 PHS_CoverLetter_1_2-1.2.pdf
54672 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
